SPDR S&P Biotech ETF (NYSEARCA:XBI) Stake Trimmed by Omnia Family Wealth LLC

Omnia Family Wealth LLC lowered its position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 0.7% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 87,600 shares of the exchange traded fund’s stock after selling 584 shares during the quarter. SPDR S&P Biotech ETF accounts for about 3.7% of Omnia Family Wealth LLC’s investment portfolio, making the stock its 6th largest position. Omnia Family Wealth LLC owned approximately 0.11% of SPDR S&P Biotech ETF worth $8,655,000 at the end of the most recent reporting period.

Several other large investors have also added to or reduced their stakes in the company. Sivik Global Healthcare LLC purchased a new position in SPDR S&P Biotech ETF during the third quarter valued at approximately $29,640,000. Pier 88 Investment Partners LLC purchased a new position in shares of SPDR S&P Biotech ETF in the third quarter worth $247,000. Oppenheimer & Co. Inc. lifted its holdings in shares of SPDR S&P Biotech ETF by 13.6% in the third quarter. Oppenheimer & Co. Inc. now owns 85,068 shares of the exchange traded fund’s stock worth $8,405,000 after buying an additional 10,168 shares in the last quarter. Hartline Investment Corp lifted its holdings in shares of SPDR S&P Biotech ETF by 2.0% in the third quarter. Hartline Investment Corp now owns 5,502 shares of the exchange traded fund’s stock worth $544,000 after buying an additional 106 shares in the last quarter. Finally, First Heartland Consultants Inc. lifted its holdings in shares of SPDR S&P Biotech ETF by 41.8% in the third quarter. First Heartland Consultants Inc. now owns 7,129 shares of the exchange traded fund’s stock worth $704,000 after buying an additional 2,100 shares in the last quarter.

SPDR S&P Biotech ETF Price Performance

Shares of XBI stock traded down $0.95 during mid-day trading on Thursday, hitting $99.06. The company had a trading volume of 3,193,412 shares, compared to its average volume of 9,315,490. SPDR S&P Biotech ETF has a 52-week low of $69.32 and a 52-week high of $105.47. The stock’s 50 day moving average price is $99.07 and its 200-day moving average price is $95.98. The company has a market capitalization of $7.55 billion, a P/E ratio of 11.47 and a beta of 1.11.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.